Learn More
Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Chair Mariell Jessup, MD, FACC, FAHA, Vice Chair Biykem Bozkurt, MD, PhD, FACC, FAHA*† Steven M. Hollenberg, MD, FACC# Javed Butler, MD, MBA, MPH, FACC,(More)
Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. Although frequently a target of therapy, its(More)
BACKGROUND Although renin-angiotensin system (RAS) inhibitors have little demonstrable effect on mortality in patients with heart failure and preserved ejection fraction (HF-PEF), some trials have(More)